⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GTBP News
GT Biopharma Inc. Common Stock
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
globenewswire.com
GTBP
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
prnewswire.com
GTBP
EVAX
RNXT
EDAP
XNCR
GTBP
EVAX
RNXT
EDAP
XNCR
Precision Oncology Approaches Drive $312B Market Transformation
prnewswire.com
GTBP
NRIX
GRAL
CCCC
PFE
GTBP
NRIX
GRAL
CCCC
PFE
Next-Generation Targeted Therapies Reshape Precision Oncology Landscape
prnewswire.com
GTBP
IDYA
ZYME
NVS
REGN
GTBP
IDYA
ZYME
NVS
REGN
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
prnewswire.com
GTBP
GDTC
PSTV
IOVA
IMAB
GTBP
GDTC
PSTV
IOVA
IMAB
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
prnewswire.com
GTBP
LXEO
ANIX
TEM
CTOR
GTBP
LXEO
ANIX
TEM
CTOR
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
globenewswire.com
GTBP
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
prnewswire.com
GTBP
LPTX
IOBT
CELC
MAIA
GTBP
LPTX
IOBT
CELC
MAIA
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
prnewswire.com
GTBP
IMAB
ENGN
ONCO
NBTX
GTBP
IMAB
ENGN
ONCO
NBTX
GT Biopharma to Participate in the Centurion One Capital 3rd Annual Bahamas Summit
globenewswire.com
GTBP